340 related articles for article (PubMed ID: 17555981)
21. The gene expression profile of extraskeletal myxoid chondrosarcoma.
Subramanian S; West RB; Marinelli RJ; Nielsen TO; Rubin BP; Goldblum JR; Patel RM; Zhu S; Montgomery K; Ng TL; Corless CL; Heinrich MC; van de Rijn M
J Pathol; 2005 Aug; 206(4):433-44. PubMed ID: 15920699
[TBL] [Abstract][Full Text] [Related]
22. Genomic expression, chemotherapy response, and molecular targets in soft tissue sarcomas of the extremities: promising strategies for treatment selection.
Aguiar S; da Cunha IW; Lopes A
J Surg Oncol; 2010 Jan; 101(1):92-6. PubMed ID: 19834919
[TBL] [Abstract][Full Text] [Related]
23. Translating gene expression into clinical care: sarcomas as a paradigm.
Nielsen TO; West RB
J Clin Oncol; 2010 Apr; 28(10):1796-805. PubMed ID: 20194847
[TBL] [Abstract][Full Text] [Related]
24. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma.
Al-Daraji WI; Makhlouf HR; Miettinen M; Montgomery EA; Goodman ZD; Marwaha JS; Fanburg-Smith JC
Am J Surg Pathol; 2009 Jun; 33(6):826-34. PubMed ID: 19194282
[TBL] [Abstract][Full Text] [Related]
25. cDNA microarray-based translational research in soft tissue sarcoma.
Lubieniecka JM; Nielsen TO
J Surg Oncol; 2005 Dec; 92(4):267-71. PubMed ID: 16299802
[TBL] [Abstract][Full Text] [Related]
26. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression signature of human sarcomas.
Subramanian S; Lui WO; Lee CH; Espinosa I; Nielsen TO; Heinrich MC; Corless CL; Fire AZ; van de Rijn M
Oncogene; 2008 Mar; 27(14):2015-26. PubMed ID: 17922033
[TBL] [Abstract][Full Text] [Related]
28. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
29. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations.
Suvà ML; Cironi L; Riggi N; Stamenkovic I
J Pathol; 2007 Oct; 213(2):117-30. PubMed ID: 17703479
[TBL] [Abstract][Full Text] [Related]
30. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
31. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
Riggi N; Cironi L; Suvà ML; Stamenkovic I
J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
[TBL] [Abstract][Full Text] [Related]
32. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
33. Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas.
Wensman H; Göransson H; Leuchowius KJ; Strömberg S; Pontén F; Isaksson A; Rutteman GR; Heldin NE; Pejler G; Hellmén E
Breast Cancer Res Treat; 2009 Nov; 118(2):333-43. PubMed ID: 19048371
[TBL] [Abstract][Full Text] [Related]
34. New molecular targets and biological therapies in sarcomas.
Scappaticci FA; Marina N
Cancer Treat Rev; 2001 Dec; 27(6):317-26. PubMed ID: 11908925
[TBL] [Abstract][Full Text] [Related]
35. The clinical relevance of molecular genetics in soft tissue sarcomas.
Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
[TBL] [Abstract][Full Text] [Related]
36. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
38. [Soft tissue sarcomas: current data in the field of pathology].
Collin F; Gelly-Marty M; Bui Nguyen Binh M; Coindre JM
Cancer Radiother; 2006; 10(1-2):7-14. PubMed ID: 16310396
[TBL] [Abstract][Full Text] [Related]
39. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
Hasegawa T
Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
[TBL] [Abstract][Full Text] [Related]
40. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations.
Verweij J; Baker LH
Eur J Cancer; 2010 Mar; 46(5):863-8. PubMed ID: 20138507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
